News & Events about Seagen Inc.
NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased ...
Seagen Inc. (NASDAQ:SGEN Get Rating) SVB Leerink increased their FY2024 earnings per share estimates for Seagen in a research report issued to clients and investors on Tuesday, April 25th. SVB Leerink analyst A. Berens now anticipates that the biotechnology company will post earnings of $0.34 per ...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGEN, SPPI, HOTH SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGEN, SPPI, HOTH PR Newswire NEW YORK, April 27, 2023 NEW YORK, April 27, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the...
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Seagen Inc. (NasdaqGS: SGEN) to Pfizer Inc. (NYSE: PFE). Under the terms of the proposed transaction, shareholders of Seagen will receive...
Seagen Inc. (Nasdaq: SGEN) today announced the presentation of 17 abstracts at the upcoming 2023 American Society of Clinical Oncology (ASCO) Annual Meeting taking place June 2-6, 2023, in Chicago. Data will be presented across Seagen's portfolio of approved medicines and pipeline agents in a range...